AbbVie (ABBV)
(Delayed Data from NYSE)
$176.95 USD
+5.22 (3.04%)
Updated Nov 22, 2024 04:00 PM ET
After-Market: $177.01 +0.06 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 35% (162 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.55 | 2.06 | 9.99 |
Current Quarter Estimate | 2.99 | 36.31 | 63.00 |
Year Ago Quarter Estimate | 2.79 | 10.25 | 52.25 |
Next Quarter Estimate | 2.62 | 35.06 | 61.00 |
Next Year Estimate | 12.19 | 171.86 | 285.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -1.62 | 8.90 | 12.40 |
Next Year | 11.53 | 9.60 | 18.75 |
Last 5 Years | 8.20 | 2.90 | 8.10 |
Next 5 Years | 7.50 | 11.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 16.46 | 21.19 |
Price/Book (MRQ) | 51.51 | 5.07 |
Price/Cash Flow (MRFY) | 11.19 | 10.85 |
Dividend Yield | 3.50% | 2.36% |
Net Profit Margin (TTM) | 9.22% | 18.31% |
Return on Equity (TTM) | 244.01% | 34.80% |
Debt to Equity (MRQ) | 9.64 | 38.52 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.